A REVIEW OF 4F MPH POWDER

It's a nootropic drug invented in 1996 by a crew working for Merck, Sharp and Dohme, that was the primary compound produced which functions as a subtype-selective inverse agonist in the α5 subtype of the benzodiazepine binding site over the GABAA receptor.4F-MPH is believed to act primarily like a dopamine and norepinephrine reuptake inhibitor, wh